-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Edesa Biotech, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Sep 2015 to 31 Dec 2025.
- Edesa Biotech, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Dec 2025 was $3,355,419, a 62% increase year-over-year.
- Edesa Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $17,030,898, a 2777% increase from 2024.
- Edesa Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $592,031, a 88% decline from 2023.
- Edesa Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4,830,111, a 58% decline from 2022.